However, analyzing our institutional database containing NGS data from 1878 melanoma specimens, we found only three SMO mutations corresponding to about 0.16% of patients (manuscript in preparation), suggesting that genetic alterations in this gene are rare in untreated patients. The gene discussed is SMO; the disease is melanoma.